| Entry |
|
|---|
| Name |
Aprobarbital (INN);
Alurate (TN) |
|---|
| Formula |
C10H14N2O3
|
|---|
| Exact mass |
210.1004
|
|---|
| Mol weight |
210.2298
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
|
|---|
| Remark |
|
|---|
| Efficacy |
Sedative-hypnotic |
|---|
| Comment |
Barubiturat
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CA Barbiturates, plain
N05CA05 Aprobarbital
D00698 Aprobarbital (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01837 Barbiturate sedative-hypnotics
D00698 Aprobarbital
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D00698 Aprobarbital (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1z C 21.9683 -18.0308
2 C5x C 21.9683 -19.4312
3 C5x C 20.7547 -17.3306
4 C1b C 21.9626 -16.6363
5 C1c C 23.3570 -18.0308
6 N1x N 20.7547 -20.1373
7 O5x O 23.1821 -20.1373
8 N1x N 19.5352 -18.0308
9 O5x O 20.7547 -15.9304
10 C2b C 23.1761 -15.9361
11 C1a C 24.0455 -16.8230
12 C1a C 24.0572 -19.2445
13 C5x C 19.5352 -19.4312
14 C2a C 23.1761 -14.5417
15 O5x O 18.3217 -20.1373
BOND 15
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 2 7 2
7 3 8 1
8 3 9 2
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 10 14 2
14 13 15 2
15 8 13 1
|
|---|
